Chemed Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Chemed Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 6.7 times. Higher than 91% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $5 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $5 tied up three years earlier. Less money tied up than 87% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$135Over the last 3 years, every $100 of reported profit came with $135 of operating cash.
Lower than 61% of Healthcare companies in United States.
Self-Funding Ratio
6.7×Over the last 3 years its own operating cash covered its investment spending (capex) 6.7 times.
Higher than 91% of Healthcare companies in United States.
Cash Locked Ratio
$5For every $100 of sales, $5 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $5 tied up three years earlier.
Less money tied up than 87% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$4Sales grew 19% in 3 years; of every extra $100 of sales, $4 became extra profit.
Lower than 63% of Healthcare companies in United States.
Asset Productivity Ratio
+19% / +7%In 3 years sales changed by +19% while total assets changed by +7%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
9.5×Debt due within a year is covered 9.5 times by its yearly operating cash.
Higher than 84% of Healthcare companies in United States.
Cash Cushion Ratio
−1%Debt, after subtracting cash, equals 1% of its market value (net debt).
Lower than 69% of Healthcare companies in United States.
Tangible Assets Ratio
51%Of every $100 the company owns, $51 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 79% of Healthcare companies in United States.
Tangible Net Worth Ratio
23%Of every $100 of net worth, $23 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 64% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Chemed Corporation owes $0.45 for every $1 it owns. Net profit fell 12% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
26.2Investors pay $26.2 for every $1 of Chemed Corporation's yearly profit, lower than 51% of Healthcare companies in United States.
P/B ratio
8.02The share price is 8.02 times Chemed Corporation's book value per share, higher than 82% of Healthcare companies in United States.
Market cap
$6.8 BThe total market value of all of Chemed Corporation's shares at today's price (share price × number of shares), larger than 87% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$848 MWhat Chemed Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
$64.88Net worth divided by the number of shares. The share price of $520.15 is 8.0 times this, which is the P/B above.
Return on equity (ROE)
27.1%Chemed Corporation earned 27.1% on its shareholders' money over the last year, higher than 93% of Healthcare companies in United States.
Owes vs Owns
0.45×Chemed Corporation owes $0.45 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.
Dividend yield
0.55%Chemed Corporation pays 0.55% of its share price as dividends a year, lower than 76% of dividend-paying Healthcare companies in United States.
Revenue growth
+4%Revenue rose 4% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Profit growth
-12%Net profit fell 12% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Profit margin
10.5%Chemed Corporation keeps $10 of every $100 of revenue as net profit.
Cash quality
1.5×Cash from Chemed Corporation's business was 1.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
194.9×Chemed Corporation's operating profit covered its interest costs 194.9 times in the year to Dec 2025.
Cash vs debt
Net debtChemed Corporation had $69 M more debt than cash (net debt) at Dec 2025.
Questions
What is Chemed Corporation's P/E ratio?
Investors pay $26.2 for every $1 of Chemed Corporation's yearly profit, lower than 51% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Chemed Corporation: $6.8 B ÷ $848 M (31 Mar 2026) = 8.0.
What is Chemed Corporation's return on equity?
Chemed Corporation earned 27.1% on its shareholders' money over the last year, higher than 93% of Healthcare companies in United States.
How much does Chemed Corporation owe compared with what it owns?
Chemed Corporation owes $0.45 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.
Does Chemed Corporation pay a dividend?
Yes. Chemed Corporation pays 0.55% of its share price as dividends a year, lower than 76% of dividend-paying Healthcare companies in United States.
Is Chemed Corporation's revenue growing?
Revenue rose 4% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.